CD4 and cancer: In tumors, we detected a higher abundance of proliferating CD8+CD39+ cancer-specific T lymphocytes and a decrease in the frequency of CD4+FoxP3+ Treg cells following infusion of GFP+Olfr644−/− and GFP+Vmn2r29−/− macrophages (Fig. 4e).